Catalent
CTLT
#1572
Rank
S$14.44 B
Marketcap
$79.59
Share price
0.73%
Change (1 day)
66.01%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : S$6.63 Billion

According to Catalent's latest financial reports the company's total debt is S$6.63 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30S$6.59 B12.26%
2022-06-30S$5.87 B34.06%
2021-06-30S$4.37 B3.64%
2020-06-30S$4.22 B5.56%
2019-06-30S$4.00 B7.94%
2018-06-30S$3.70 B29.38%
2017-06-30S$2.86 B14.43%
2016-06-30S$2.50 B-1.11%
2015-06-30S$2.53 B-25.22%
2014-06-30S$3.38 B-0.68%
2013-06-30S$3.41 B0.31%
2012-06-30S$3.40 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$51.17 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.45 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.31 B 25.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$0.30 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA